Andrew Combs

Insider Reports History

Entity
Individual
Location
C/O Prelude Therapeutics Incorporated, 200 Powder Mill Road, Wilmington, DE
Signature
/s/ Laurent Chardonnet, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Combs:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Prelude Therapeutics Inc Chief Chemistry Officer Employee Stock Option (right to buy) 150K Mar 1, 2024 Direct

Insider Reports Filed by Andrew Combs

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRLD Prelude Therapeutics Inc Mar 1, 2024 1 $0 4 Mar 4, 2024 Chief Chemistry Officer
PRLD Prelude Therapeutics Inc Feb 7, 2023 1 $0 4 Feb 9, 2023 EVP, Head of Chemistry
PRLD Prelude Therapeutics Inc Mar 31, 2022 2 $68.2K 4 Apr 4, 2022 EVP, Head of Chemistry
PRLD Prelude Therapeutics Inc Feb 15, 2022 1 $0 4 Feb 17, 2022 EVP, Head of Chemistry
PRLD Prelude Therapeutics Inc Dec 13, 2021 2 $94.9K 4 Dec 15, 2021 EVP, Head of Chemistry
PRLD Prelude Therapeutics Inc Jul 20, 2021 1 $0 4 Jul 22, 2021 EVP, Head of Chemistry